Compare Davita Inc (DVA) vs iShares Core High Dividend ETF (HDV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs iShares Core High Dividend ETF — how do they compare? Davita Inc trades at $179.05 (market cap $11.29B), while iShares Core High Dividend ETF trades at $28.71 (market cap $14.68B). The key difference: iShares Core High Dividend ETF is the larger of the two by market cap, and iShares Core High Dividend ETF is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 114 Days and iShares Core High Dividend ETF for 117 Days on average.
| DVA | HDV | |
|---|---|---|
Market Cap | $11.29B | $14.68B |
Volume | 582,204 | 2,925,562 |
Sector | Health | — |
52-Week High | $240.96 | $29.93 |
52-Week Low | $103.87 | $23.64 |
Typical Hold Time | 114 Days | 117 Days |
Enterprise Value | $24.01B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $179.25, up 1.4% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows mixed technical signals with bearish moving averages but neutral oscillators, trading near resistance at $179. Fundamentally, revenue growth continues with 2025 revenue reaching $13.64B, though net margins compressed to 5.47% from 7.3% in 2024. Recent partnership expansion with Humana for value-based kidney care represents significant growth opportunity.
Outlook remains positive with analyst consensus target of $235.67 implying 31% upside, though elevated debt levels and regulatory risks require monitoring. The company benefits from demographic tailwinds in kidney care services and strong institutional support, including Berkshire Hathaway's 45% stake, providing stability amid market volatility.
HDV (iShares Core High Dividend ETF) trades at $28.71, up 1.52% with a bullish technical signal. Recent sector rebalancing reduced healthcare exposure by nearly half while increasing energy, staples, and utilities, creating concentration risk with 62% in three sectors. The ETF yields approximately 3% but faces questions about whether this compensates for reduced diversification. Technical indicators show strong momentum with RSI at 77.74 suggesting potential overbought conditions.
The outlook remains cautiously optimistic given HDV's 2026 outperformance against the S&P 500, though the concentrated sector allocation and moderate yield present both opportunity and risk. Investors should weigh the fund's recent structural changes against its dividend income generation capabilities in a rising rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About iShares Core High Dividend ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.
Read more on HDV →
